Ardelyx, Inc. (ARDX)
USD 4.61
(-1.07%)
USD 4.61
(-1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -89.71 Million | -70.04 Million | -152.55 Million | -81.43 Million | -76.48 Million | -70.27 Million |
| Net Income | -66.06 Million | -67.2 Million | -158.16 Million | -94.31 Million | -94.94 Million | -91.29 Million |
| Depreciation & Amortization | 1.29 Million | 1.14 Million | 1.44 Million | 1.82 Million | 2.5 Million | 2.67 Million |
| Deferred income taxes | - | - | -190 Thousand | 315 Thousand | -262 Thousand | -1.02 Million |
| Stock-based compensation | 13.53 Million | 10.75 Million | 12.03 Million | 10.58 Million | 9.93 Million | 9.22 Million |
| Change in working capital | -43.38 Million | -19.57 Million | -11.92 Million | -3.21 Million | 2.98 Million | 9.35 Million |
| Other non-cash items | 4.91 Million | 4.84 Million | 4.24 Million | 3.36 Million | 3.29 Million | 792 Thousand |
| Investing Cash Flow | -131.24 Million | 18.41 Million | 50.94 Million | -31.44 Million | 23.37 Million | -29.89 Million |
| Investments in PPE | -344 Thousand | -55 Thousand | -1.86 Million | -324 Thousand | -325 Thousand | -311 Thousand |
| Acquisitions | 130.9 Million | 1.79 Million | -52.81 Million | 31.44 Million | -23.69 Million | - |
| Investment purchases | -215.22 Million | -50.32 Million | -72.73 Million | -150.85 Million | -102.67 Million | -169.03 Million |
| Sales/Maturities of investments | 84.32 Million | 67 Million | 125.55 Million | 119.73 Million | 126.36 Million | 139.45 Million |
| Other Investing Activities | -130.9 Million | 18.47 Million | 52.81 Million | -31.44 Million | 23.69 Million | -29.58 Million |
| Financing Cash Flow | 146.29 Million | 75.34 Million | 82.99 Million | 22.77 Million | 155.47 Million | 103.55 Million |
| Debt repayment | -25.88 Million | -6.06 Million | -19.44 Million | -125 Thousand | - | -49.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.17 Million | - | -106 Thousand | - | - | - |
| Common Stock Issuance | 120.4 Million | 71.82 Million | 102.54 Million | 21.04 Million | 154.9 Million | 53.77 Million |
| Other Financing Activities | 3.5 Million | 81.4 Million | -106 Thousand | 1.85 Million | 574 Thousand | 49.78 Million |
| Accounts receivables | -14.29 Million | -7.23 Million | -502 Thousand | 750 Thousand | 85 Thousand | 10.71 Million |
| Accounts payables | 279 Thousand | 6.58 Million | -1.34 Million | 3.43 Million | 39 Thousand | -2.73 Million |
| Inventory | -21.14 Million | -28.34 Million | -10.37 Million | -750 Thousand | -3.41 Million | 1.87 Million |
| Other working capital | -8.22 Million | 9.42 Million | 300 Thousand | -6.65 Million | 6.27 Million | -506 Thousand |
| Cash at beginning of period | 96.14 Million | 72.42 Million | 91.03 Million | 181.13 Million | 78.76 Million | 75.38 Million |
| Cash at end of period | 21.47 Million | 96.14 Million | 72.42 Million | 91.03 Million | 181.13 Million | 78.76 Million |
| Capital Expenditure | -344 Thousand | -55 Thousand | -1.86 Million | -324 Thousand | -325 Thousand | -311 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -74.67 Million | 23.71 Million | -18.6 Million | -90.1 Million | 102.36 Million | 3.38 Million |
| Free Cash Flow | -90.06 Million | -70.09 Million | -154.41 Million | -81.75 Million | -76.8 Million | -70.58 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -809 Thousand | -16.45 Million | -26.51 Million | -66.06 Million | -28.8 Million | 6.62 Million |
| Depreciation & Amortization | 544 Thousand | 569 Thousand | 435 Thousand | 1.29 Million | 362 Thousand | 291 Thousand |
| Deferred income taxes | - | - | - | - | 499 Thousand | - |
| Stock-based compensation | 9.13 Million | 10.76 Million | 7.61 Million | 13.53 Million | 3.93 Million | 3.48 Million |
| Change in working capital | 33.45 Million | -14.76 Million | -18.69 Million | -43.38 Million | 15.17 Million | -32.78 Million |
| Other non-cash items | -41.81 Million | 32.43 Million | 39.28 Million | 4.91 Million | 115 Thousand | 910 Thousand |
| Investing Cash Flow | 2.34 Million | 23.53 Million | -2.57 Million | -131.24 Million | -29.56 Million | -32.69 Million |
| Investments in PPE | -137 Thousand | -131 Thousand | -150 Thousand | -344 Thousand | -43 Thousand | -194 Thousand |
| Acquisitions | - | - | - | 130.9 Million | 29.52 Million | 32.5 Million |
| Investment purchases | -39.76 Million | -22.84 Million | -34.02 Million | -215.22 Million | -77.58 Million | -49.51 Million |
| Sales/Maturities of investments | 42.24 Million | 46.51 Million | 31.6 Million | 84.32 Million | 48.05 Million | 17.01 Million |
| Other Investing Activities | - | 23.66 Million | -2.42 Million | -130.9 Million | -29.52 Million | -32.5 Million |
| Financing Cash Flow | 2.69 Million | 1.6 Million | 52.97 Million | 146.29 Million | 25.98 Million | 57.87 Million |
| Debt repayment | -49.75 Million | - | -49.75 Million | -25.88 Million | -25.88 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 4.3 Million | - | 3.22 Million | 1.17 Million | 303 Thousand | 670 Thousand |
| Common Stock Issuance | -4.57 Million | 1.6 Million | 3.22 Million | 120.4 Million | 102 Thousand | 57.87 Million |
| Other Financing Activities | 52.71 Million | 1.6 Million | 49.75 Million | 3.5 Million | 25.98 Million | 57.87 Million |
| Accounts receivables | -15.95 Million | -9.07 Million | -6.13 Million | -14.29 Million | 21.23 Million | -34.15 Million |
| Accounts payables | 3.94 Million | -6.39 Million | 6.13 Million | 279 Thousand | 3.4 Million | 2.44 Million |
| Inventory | -1.72 Million | -4.57 Million | -29.37 Million | -21.14 Million | -1.98 Million | 414 Thousand |
| Other working capital | -15.96 Million | 5.28 Million | 10.67 Million | -8.22 Million | -7.46 Million | -1.48 Million |
| Cash at beginning of period | 41.89 Million | 36.14 Million | 21.47 Million | 96.14 Million | 33.76 Million | 30.05 Million |
| Cash at end of period | 47.42 Million | 41.89 Million | 36.14 Million | 21.47 Million | 21.47 Million | 33.76 Million |
| Capital Expenditure | -137 Thousand | -131 Thousand | -150 Thousand | -344 Thousand | -43 Thousand | -194 Thousand |
| Effect of forex changes on cash | - | - | - | - | -212.76 Million | 64.24 Million |
| Net cash flow / Change in cash | 5.53 Million | 5.74 Million | 14.67 Million | -74.67 Million | -12.29 Million | 3.7 Million |
| Free Cash Flow | 364 Thousand | -19.52 Million | -35.87 Million | -90.06 Million | -8.76 Million | -21.66 Million |
PMTA
3563
HEMO
NPPXF
0Z1W
3016